title: Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery.
authors.affiliation: James Cook University Hospital, Middlesbrough, UK.
authors.forename: Joel
authors.initials: J
authors.lastname: Dunning
authors.forename: Tom
authors.initials: T
authors.lastname: Treasure
authors.forename: Michael
authors.initials: M
authors.lastname: Versteegh
authors.forename: Samer A M
authors.initials: SA
authors.lastname: Nashef
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D011182:Postoperative Care / Q000379:methods*; D013015:Sotalol / Q000627:therapeutic use; D019616:Thoracic Surgical Procedures / Q000009:adverse effects*
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D013015:Sotalol; D008274:Magnesium; D000638:Amiodarone